Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)

← catalyst calendar

NCT04822181 · readout in 980 d

Sponsored by Novo Nordisk A/S (industry) · NVO — their whole pipeline →.

Phase
Phase 3
Status
Active, not recruiting
Study type
Interventional
Design
Randomized · Double · Treatment
Enrollment
1,205actual
Sites
557
Countries
Argentina, Australia, Austria +36

Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →

Source: ClinicalTrials.gov, retrieved 2026-08-19

Dates

each axis at the precision it was filed, with the registry's own basis
DateFiledBasisWhat it is
Start2021-04-01actualWhen the study began enrolling
Primary completion2029-04-25estimatedThe date the last participant is measured for the primary outcome — the readout window
Study completion2029-04-25estimatedThe whole study's end, after follow-up
First posted2021-03-30actualWhen this record first appeared on the registry
Results postedWhen the sponsor posted results to the registry
Record updated2026-08-04actualThe sponsor's own last edit to this record — every projection above is as current as this date

What it studies

Condition

  • Non-alcoholic Steatohepatitis

Interventions

  • Drug: Semaglutide
  • Drug: Placebo

Primary outcomes

what the primary-completion date above is the date OF
Part 1: Resolution of steatohepatitis and no worsening of liver fibrosis (Yes/No)
measured From randomisation (week 0) to week 72
Part 1: Improvement in liver fibrosis and no worsening of steatohepatitis (Yes/No)
measured From randomisation (week 0) to week 72
Part 2: Cirrhosis-free survival (Yes/No)
measured From randomisation (week 0) to week 240

Publications

Linked on the registry record. A “linked by the registry” entry is NLM's own automated PubMed match, not a claim by the sponsor that the paper reports this study.

Permalink · NVO's whole pipeline · Catalyst calendar · Every registered study · What changed